Prostate cancer screening in the general population:: the drawbacks are certain but the benefits are hypothetical

被引：10

作者：

Auperin, Anne ^{[1
]}

Laplanche, Agnes ^{[1
]}

Hill, Catherine ^{[1
]}

机构：

[1] Inst Gustave Roussy, Serv Biostat & Epidemiol, F-94805 Villejuif, France

来源：

PRESSE MEDICALE | 2007年 / 36卷 / 7-8期

关键词：

D O I：

10.1016/j.lpm.2007.04.008

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

The main drawback of prostate cancer screening is overdiagnosis i.e. the detection of cancers that would never hove become symptomatic, their treatment leads in many cases to impotence or urinary incontinence. Prostate cancer screening cannot be recommended at the present time because it has not yet been shown to reduce mortality from prostate cancer. The first results on mortality from 2 large trials of prostate cancer screening, conducted in Europe and in the United States, will not be available before 2008.

引用

页码：1045 / 1053

页数：9

共 44 条

[1]

*AG NAT ACCR EV SA, 1998, OPP DEP SYST CANC PR

[2]

*AG NAT ACCR EV SA, 2001, SERV EV TECHN SERV E

[3]

*AG NAT ACCR EV SA, 2004, SERV REC PROF SERV E

[4]

Prostate cancer screening in the prostate, lung, colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings from the initial screening round of a randomized trial [J].

Andriole, GL ;

Levin, DL ;

Crawford, ED ;

Gelmann, ER ;

Pinsky, PF ;

Chia, D ;

Kramer, BS ;

Reding, D ;

Church, TR ;

Grubb, RL ;

Izmirlian, G ;

Ragard, LR ;

Clapp, JD ;

Prorok, PC ;

Gohagan, JK .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06) :433-438

[5]

TRANSRECTAL ULTRASOUND EXAMINATION OF THE PROSTATE - COMPLICATIONS AND ACCEPTANCE BY PATIENTS [J].

AUS, G ;

HERMANSSON, CG ;

HUGOSSON, J ;

PEDERSEN, KV .

BRITISH JOURNAL OF UROLOGY, 1993, 71 (04) :457-459

[6]

Test sensitivity of prostate-specific antigen in the Finnish randomised prostate cancer screening trial [J].

Auvinen, A ;

Määttänen, L ;

Finne, P ;

Stenman, UH ;

Aro, J ;

Juusela, H ;

Rannikko, S ;

Tammela, TLJ ;

Hakama, M .

INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (06) :940-943

[7]

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria [J].

Bartsch, G ;

Horninger, W ;

Klocker, H ;

Reissigl, A ;

Oberaigner, W ;

Schönitzer, D ;

Severi, G ;

Robertson, C ;

Boyle, P .

UROLOGY, 2001, 58 (03) :417-424

[8]

Radical prostatectomy versus watchful waiting in early prostate cancer [J].

Bill-Axelson, A ;

Holmberg, L ;

Ruutu, M ;

Häggman, M ;

Andersson, SO ;

Bratell, S ;

Spångberg, A ;

Busch, C ;

Nordling, S ;

Garmo, H ;

Palmgren, J ;

Adami, HO ;

Norlén, BJ ;

Johansson, JE .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (19) :1977-1984

[9]

Bloch J, 2005, DEPISTAGE CANC SEIN

[10]

CLINICAL-EVIDENCE FOR AND IMPLICATIONS OF THE MULTISTEP DEVELOPMENT OF PROSTATE-CANCER [J].

CARTER, HB ;

PIANTADOSI, S ;

ISAACS, JT .

JOURNAL OF UROLOGY, 1990, 143 (04) :742-746

← 1 2 3 4 5 →